FDA Inspection 616111 — Sher Institute For Reproductive Medicine New Jersey P.A.
The FDA completed an inspection of Sher Institute For Reproductive Medicine New Jersey P.A. on Sep 29, 2009 in Phillipsburg, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 29, 2009
- Fiscal Year
- 2009
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Phillipsburg, NJ (United States)